Dr Phillip Read

Carson JM; Hajarizadeh B; Hanson J; O'Beirne J; Iser D; Read P; Balcomb A; Davies J; Doyle JS; Yee J; Martinello M; Marks P; Matthews GV; Dore GJ; Post J; Batey R; Smart J; Dawson O; Hill S; Douglas M; Montebello M; Collie P; Hallinan R; Snelgar G; Baker D; Galhenage S; Soo TM; Bopage R; Faros J; Cooper L; Nelson R; Shaw D; Wilson M; Pratt W; Hinton S; Wade A; Van Gessel H; Davidson L; Dibdin M; Lucas M; Ahmad R; Smith D; Tan K; Roder C; Harney B; Holdaway S; Walsh J; Fox P; Mousavi R; Lam W; Dahal RP; Habel P; Gilliver R; Silins E; Ackerman J; Deacon R; Hall E; Everson A; Stewart J; Milner M; Ferguson C; Tate-Baker J; Bradshaw J; Duncan G; Baluran G; Watson B; Hey C; Hickey R; Orme C; Miczkova S, 2022, 'Retreatment for hepatitis C virus direct-acting antiviral therapy virological failure in primary and tertiary settings: The REACH-C cohort', Journal of Viral Hepatitis, vol. 29, pp. 661 - 676, http://dx.doi.org/10.1111/jvh.13705

Wheeler A; Valerio H; Cunningham EB; Martinello M; Barocas JA; Colledge-Frisby S; Treloar C; Amin J; Henderson C; Read P; Matthews GV; Dunlop AJ; Gorton C; Hayllar J; Alavi M; Murray C; Marks P; Silk D; Degenhardt L; Dore GJ; Grebely J, 2022, 'Prevalence and factors associated with hospitalisation for bacterial skin infections among people who inject drugs: The ETHOS Engage Study', Drug and Alcohol Dependence, vol. 237, pp. 109543, http://dx.doi.org/10.1016/j.drugalcdep.2022.109543

Monds LA; Bravo M; Mills L; Malcolm A; Gilliver R; Wood W; Harrod ME; Read P; Nielsen S; Dietze PM; Lenton S; Bleeker AM; Lintzeris N, 2022, 'The Overdose Response with Take Home Naloxone (ORTHN) project: Evaluation of health worker training, attitudes and perceptions', Drug and Alcohol Review, vol. 41, pp. 1085 - 1094, http://dx.doi.org/10.1111/dar.13474

Conway A; Valerio H; Alavi M; Silk D; Treloar C; Hajarizadeh B; Marshall AD; Martinello M; Milat A; Dunlop A; Murray C; Prain B; Henderson C; Amin J; Read P; Marks P; Degenhardt L; Hayllar J; Reid D; Gorton C; Lam T; Christmass M; Wade A; Montebello M; Dore GJ; Grebely J, 2022, 'A Testing Campaign Intervention Consisting of Peer-Facilitated Engagement, Point-of-Care HCV RNA Testing, and Linkage to Nursing Support to Enhance Hepatitis C Treatment Uptake among People Who Inject Drugs: The ETHOS Engage Study', Viruses, vol. 14, http://dx.doi.org/10.3390/v14071555

Yee J; Carson JM; Hajarizadeh B; Hanson J; O’Beirne J; Iser D; Read P; Balcomb A; Doyle JS; Davies J; Martinello M; Marks P; Dore GJ; Matthews GV; Hanson J; Read P; Carson J; Byrne M; Post J; Doyle J; Batey R; Smart J; Dawson O; Hill S; Douglas M; Montebello M; Collie P; Hallinan R; Snelgar G; Baker D; Galhenage S; Soo TM; Read P; Bopage R; Faros J; Cooper L; Nelson R; Shaw D; Davies J; Wilson M; Pratt W; Hinton S; Wade A; Van Gessel H; Davidson L; Dibdin M; Lucas M; Ahmad R; Smith D; Tan K; Roder C; Harney B; Holdaway S; Walsh J; Fox P; Mousavi R; Lam W; Dahal RP; Habel P; Gilliver R; Silins E; Ackerman J; Deacon R; Hall E; Everson A; Milner M; Ferguson C; Tate-Baker J; Bradshaw J; Duncan G; Baluran G; Watson B; Hey C; Hickey R; Orme C; Miczkova S, 2022, 'High Effectiveness of Broad Access Direct-Acting Antiviral Therapy for Hepatitis C in an Australian Real-World Cohort: The REACH-C Study', Hepatology Communications, vol. 6, pp. 496 - 512, http://dx.doi.org/10.1002/hep4.1826

Valerio H; Alavi M; Conway A; Silk D; Treloar C; Martinello M; Milat A; Dunlop A; Murray C; Henderson C; Amin J; Read P; Marks P; Degenhardt L; Stevens A; Prain B; Hayllar J; Reid D; Montebello M; Wade A; Christmass M; Cock V; Dore GJ; Grebely J; ETHOS Engage Study Group , 2022, 'Declining prevalence of current HCV infection and increased treatment uptake among people who inject drugs: The ETHOS Engage study.', Int J Drug Policy, vol. 105, pp. 103706, http://dx.doi.org/10.1016/j.drugpo.2022.103706

Gibbs D; Price O; Grebely J; Larney S; Sutherland R; Read P; Butler K; Degenhardt L; Peacock A, 2021, 'Hepatitis C virus cascade of care among people who inject drugs in Australia: Factors associated with testing and treatment in a universal healthcare system', Drug and Alcohol Dependence, vol. 228, pp. 109050, http://dx.doi.org/10.1016/j.drugalcdep.2021.109050

Matthews GV; Bhagani S; Van der Valk M; Rockstroh J; Feld JJ; Rauch A; Thurnheer C; Bruneau J; Kim A; Hellard M; Shaw D; Gane E; Nelson M; Ingiliz P; Applegate TL; Grebely J; Marks P; Martinello M; Petoumenos K; Dore GJ; Marks P; Amjad S; Tu E; Tamaddoni M; Thurnheer MC; Gilleece Y; Fraser C; Moriggia A; Lutz T; Moon J; Read P; Kim AY; Ustianowski A; Cordes C; Sasadeusz J; Hull M; Braun D, 2021, 'Sofosbuvir/velpatasvir for 12 vs. 6 weeks for the treatment of recently acquired hepatitis C infection', Journal of Hepatology, vol. 75, pp. 829 - 839, http://dx.doi.org/10.1016/j.jhep.2021.04.056

Carson JM; Hajarizadeh B; Hanson J; O'Beirne J; Iser D; Read P; Balcomb A; Davies J; Doyle JS; Yee J; Martinello M; Marks P; Dore GJ; Matthews GV, 2021, 'Effectiveness of treatment for hepatitis C virus reinfection following direct acting antiviral therapy in the REACH-C cohort', International Journal of Drug Policy, vol. 96, pp. 103422, http://dx.doi.org/10.1016/j.drugpo.2021.103422

Conway A; Valerio H; Peacock A; Degenhardt L; Hayllar J; Harrod ME; Henderson C; Read P; Gilliver R; Christmass M; Dunlop A; Montebello M; Whitton G; Reid D; Lam T; Alavi M; Silk D; Marshall AD; Treloar C; Dore GJ; Grebely J, 2021, 'Non-fatal opioid overdose, naloxone access, and naloxone training among people who recently used opioids or received opioid agonist treatment in Australia: The ETHOS Engage study', International Journal of Drug Policy, vol. 96, pp. 103421, http://dx.doi.org/10.1016/j.drugpo.2021.103421

Chan C; Patel P; Johnson K; Vaughan M; Price K; McNulty A; Templeton D; Read P; Cunningham P; Grulich A; Bavinton B, 2021, 'Community-based peer-led HIV/sexually transmitted infection testing services in Sydney for gay and bisexual men captured an eighth of new HIV diagnoses in New South Wales, Australia', AIDS, http://dx.doi.org/10.1097/QAD.0000000000002982

Patel PG; Keen P; McManus H; Duck T; Callander D; Selvey C; Power C; Gray RT; Knight V; Asselin J; Read P; Johnson K; Bavinton BR; Bowden VJ; Grulich AE; Guy R; Prestage G; Zablotska I; Holden J; Cooper C; Price K; Holt M; de Wit J; Kaldor J; Kelleher A; Wilson D; Brotherton A; Cooper DA; Crooks L; Whittaker B; Madeddu D; Schmidt HM; Telfer B; Boyd M; McGill S; Pinto A; Nigro S; Gordon T; Feeney L; Cunningham P; Mao L; Gray J; O’Dwyer M; Clifton B, 2021, 'Increased targeted HIV testing and reduced undiagnosed HIV infections among gay and bisexual men', HIV Medicine, vol. 22, pp. 605 - 616, http://dx.doi.org/10.1111/hiv.13102

Grulich AE; Jin F; Bavinton BR; Yeung B; Hammoud MA; Amin J; Cabrera G; Clackett S; Ogilvie E; Vaccher S; Vickers T; McNulty A; Smith DJ; Dharan NJ; Selvey C; Power C; Price K; Zablotska I; Baker DA; Bloch M; Brown K; Carmody CJ; Carr A; Chanisheff D; Doong N; Finlayson R; Lewis DA; Lusk J; Martin S; Ooi C; Read P; Ryder N; Smith D; Tuck Meng Soo C; Templeton DJ; Vlahakis E; Guy R, 2021, 'Long-term protection from HIV infection with oral HIV pre-exposure prophylaxis in gay and bisexual men: findings from the expanded and extended EPIC-NSW prospective implementation study', The Lancet HIV, vol. 8, pp. e486 - e494, http://dx.doi.org/10.1016/S2352-3018(21)00074-6

Valerio H; Alavi M; Silk D; Treloar C; Martinello M; Milat A; Dunlop A; Holden J; Henderson C; Amin J; Read P; Marks P; Degenhardt L; Hayllar J; Reid D; Gorton C; Lam T; Dore GJ; Grebely J, 2021, 'Progress towards Elimination of Hepatitis C Infection among People Who Inject Drugs in Australia: The ETHOS Engage Study', Clinical Infectious Diseases, vol. 73, pp. E69 - E78, http://dx.doi.org/10.1093/cid/ciaa571

Grebely J; Tran L; Degenhardt L; Dowell-Day A; Santo T; Larney S; Hickman M; Vickerman P; French C; Butler K; Gibbs D; Valerio H; Read P; Dore GJ; Hajarizadeh B, 2021, 'Association between Opioid Agonist Therapy and Testing, Treatment Uptake, and Treatment Outcomes for Hepatitis C Infection among People Who Inject Drugs: A Systematic Review and Meta-analysis', Clinical Infectious Diseases, vol. 73, pp. E107 - E118, http://dx.doi.org/10.1093/cid/ciaa612

Cunningham EB; Hajarizadeh B; Amin J; Hellard M; Bruneau J; Feld JJ; Cooper C; Powis J; Litwin AH; Marks P; Dalgard O; Conway B; Moriggia A; Stedman C; Read P; Bruggmann P; Lacombe K; Dunlop A; Applegate TL; Matthews GV; Fraser C; Dore GJ; Grebely J, 2021, 'Reinfection Following Successful Direct-acting Antiviral Therapy for Hepatitis C Virus Infection among People Who Inject Drugs', Clinical Infectious Diseases, vol. 72, pp. 1392 - 1400, http://dx.doi.org/10.1093/cid/ciaa253

Cunningham EB; Hajarizadeh B; Amin J; Litwin AH; Gane E; Cooper C; Lacombe K; Hellard M; Read P; Powis J; Dalgard O; Bruneau J; Matthews GV; Feld JJ; Dillon JF; Shaw D; Bruggmann P; Conway B; Fraser C; Marks P; Dore GJ; Grebely J, 2020, 'Adherence to once-daily and twice-daily direct-acting antiviral therapy for Hepatitis C infection among people with recent injection drug use or current opioid agonist therapy', Clinical Infectious Diseases, vol. 71, pp. E115 - E124, http://dx.doi.org/10.1093/cid/ciz1089

Martinello M; Yee J; Bartlett SR; Read P; Baker D; Post JJ; Finlayson R; Bloch M; Doyle J; Shaw D; Hellard M; Petoumenos K; Lin L; Marks P; Applegate T; Dore GJ; Matthews GV, 2020, 'Moving towards Hepatitis C microelimination among people living with human immunodeficiency virus in Australia: The CEASE study', Clinical Infectious Diseases, vol. 71, pp. 1502 - 1510, http://dx.doi.org/10.1093/cid/ciz985

Artenie AA; Cunningham EB; Dore GJ; Conway B; Dalgard O; Powis J; Bruggmann P; Hellard M; Cooper C; Read P; Feld JJ; Hajarizadeh B; Amin J; Lacombe K; Stedman C; Litwin AH; Marks P; Matthews GV; Quiene S; Erratt A; Bruneau J; Grebely J, 2020, 'Patterns of drug and alcohol use and injection equipment sharing among people with recent injecting drug use or receiving opioid agonist treatment during and following hepatitis c virus treatment with directacting antiviral therapies: An international study', Clinical Infectious Diseases, vol. 70, pp. 2369 - 2376, http://dx.doi.org/10.1093/cid/ciz633

Grebely J; Read P; Cunningham EB; Weltman M; Matthews GV; Dunlop A; Montebello M; Martinello M; Gilliver R; Marks P; Applegate TL; Dore GJ, 2020, 'Elbasvir and grazoprevir for hepatitis C virus genotype 1 infection in people with recent injecting drug use (DARLO-C): An open-label, single-arm, phase 4, multicentre trial', Health Science Reports, vol. 3, pp. e151, http://dx.doi.org/10.1002/hsr2.151

Bajis S; Grebely J; Hajarizadeh B; Applegate T; Marshall AD; Ellen Harrod M; Byrne J; Bath N; Read P; Edwards M; Gorton C; Hayllar J; Cock V; Peterson S; Thomson C; Weltman M; Jefferies M; Wood W; Haber P; Ezard N; Martinello M; Maher L; Dore GJ; Peolim L; How-Chow D; Telenta J; Harvey P; Jones S; Dunlop A; Treloar C; Samuel Y; Poeder F; Crawford S; Baxter A; Keats J; Mowat Y; Silk D; Micallef M; Tamaddoni M; Marks P; Lamoury F; Jayasinghe I; Reid H; Cunningham EB; Bartlett S; Jacka B; Erratt A; Jauncey M; Collie P; Lam T; Gilliver R; Hazelwood S; Houlihan N; Burns C; Lewis R; Morris D; Donohue K; Carthew A; Horasak N; Cherry R; Shin S; Peterson D; Sellwood T; McKeown W; Pritchard-Jones J; Smyth F; Adey S; Clark K, 2020, 'Hepatitis C virus testing, liver disease assessment and treatment uptake among people who inject drugs pre- and post-universal access to direct-acting antiviral treatment in Australia: The LiveRLife study', Journal of Viral Hepatitis, vol. 27, pp. 281 - 293, http://dx.doi.org/10.1111/jvh.13233

Gilliver R; Kearley J; Read P, 2020, 'Preparing for a syndemic: incorporating opioid overdose management into routine care for people who inject drugs initiating hepatitis C treatment', Internal Medicine Journal, vol. 50, pp. 382 - 383, http://dx.doi.org/10.1111/imj.14755

Lintzeris N; Monds LA; Bravo M; Read P; Harrod ME; Gilliver R; Wood W; Nielsen S; Dietze PM; Lenton S; Shanahan M; Jauncey M; Jefferies M; Hazelwood S; Dunlop AJ; Greenaway M; Haber P; Ezard N; Malcom A, 2020, 'Designing, implementing and evaluating the overdose response with take-home naloxone model of care: An evaluation of client outcomes and perspectives', Drug and Alcohol Review, vol. 39, pp. 55 - 65, http://dx.doi.org/10.1111/dar.13015

Hosseini-Hooshyar S; Martinello M; Yee J; Read P; Baker D; Post JJ; Finlayson R; Bloch M; Doyle JS; Shaw D; Hellard M; Petoumenos K; Carson J; Dore GJ; Matthews GV, 2020, 'Low hepatitis C virus reinfection rate despite ongoing risk following universal access to direct-acting antiviral therapy among people living with HIV', AIDS, vol. 34, pp. 1347 - 1358, http://dx.doi.org/10.1097/QAD.0000000000002562

Read P; Gilliver R; Kearley J; Lothian R; Cunningham EB; Chronister KJ; Dore GJ, 2019, 'Treatment adherence and support for people who inject drugs taking direct-acting antiviral therapy for hepatitis C infection', Journal of Viral Hepatitis, vol. 26, pp. 1301 - 1310, http://dx.doi.org/10.1111/jvh.13175

Callander D; Cook T; Read P; Hellard ME; Fairley CK; Kaldor JM; Vlahakis E; Pollack A; Bourne C; Russell DB; Guy RJ; Donovan B, 2019, 'Sexually transmissible infections among transgender men and women attending Australian sexual health clinics', Medical Journal of Australia, vol. 211, pp. 406 - 411, http://dx.doi.org/10.5694/mja2.50322

Lazarus JV; Pericàs JM; Picchio C; Cernosa J; Hoekstra M; Luhmann N; Maticic M; Read P; Robinson EM; Dillon JF, 2019, 'We know DAAs work, so now what? Simplifying models of care to enhance the hepatitis C cascade', Journal of Internal Medicine, vol. 286, pp. 503 - 525, http://dx.doi.org/10.1111/joim.12972

Bajis S; Grebely J; Cooper L; Smith J; Owen G; Chudleigh A; Hajarizadeh B; Martinello M; Adey S; Read P; Gilliver R; Applegate T; Treloar C; Maher L; Dore GJ, 2019, 'Hepatitis C virus testing, liver disease assessment and direct-acting antiviral treatment uptake and outcomes in a service for people who are homeless in Sydney, Australia: The LiveRLife homelessness study', Journal of Viral Hepatitis, vol. 26, pp. 969 - 979, http://dx.doi.org/10.1111/jvh.13112

Chronister KJ; Lothian R; Gilliver R; Kearley J; Read P, 2019, 'Feasibility and acceptability of adherence support for direct acting antiviral therapy for hepatitis C in a low-threshold primary health-care opioid agonist treatment program', Drug and Alcohol Review, vol. 38, pp. 185 - 189, http://dx.doi.org/10.1111/dar.12903

Read P; Chronister KJ; Kostovski C; Harrod ME; Salmon A; Jauncey M, 2019, 'Perceptions of people who inject drugs towards HIV pre-exposure prophylaxis in Australia', Sexual Health, vol. 16, pp. 383 - 388, http://dx.doi.org/10.1071/SH18228

Hooshyar SH; Martinello M; Yee J; Bartlett S; Read P; Baker D; Post J; Finlayson R; Bloch M; Doyle J; Shaw D; Hellard M; Petoumenos K; Marks P; Applegate T; Dore G; Matthews G, 2019, 'SAT-235-Low HCV reinfection incidence following DAA treatment scale-up in people living with HIV in Australia', Journal of Hepatology, vol. 70, pp. e734 - e734, http://dx.doi.org/10.1016/s0618-8278(19)31468-9

Grebely J; Cunningham EB; Dalgard O; Hajarizadeh B; Conway B; Powis J; Bruneau J; Feld J; Read P; Cooper C; Amin J; Bruggmann P; Lacombe K; Stedman C; Hellard M; Marks P; Dunlop A; Moriggia A; Applegate T; Litwin A; Matthews G; Dore G, 2019, 'SAT-232-Reinfection following successful HCV DAA therapy among people with recent injecting drug use', Journal of Hepatology, vol. 70, pp. e732 - e733, http://dx.doi.org/10.1016/s0618-8278(19)31465-3

Cunningham EB; Amin J; Feld JJ; Bruneau J; Dalgard O; Powis J; Hellard M; Cooper C; Read P; Conway B; Dunlop AJ; Norton B; Litwin AH; Hajarizadeh B; Thurnheer MC; Dillon JF; Weltman M; Shaw D; Bruggmann P; Gane E; Fraser C; Marks P; Applegate TL; Quiene S; Siriragavan S; Matthews GV; Dore GJ; Grebely J, 2018, 'Adherence to sofosbuvir and velpatasvir among people with chronic HCV infection and recent injection drug use: The SIMPLIFY study', International Journal of Drug Policy, vol. 62, pp. 14 - 23, http://dx.doi.org/10.1016/j.drugpo.2018.08.013

Grulich AE; Guy R; Amin J; Jin F; Selvey C; Holden J; Schmidt HMA; Zablotska I; Price K; Whittaker B; Chant K; Cooper C; McGill S; Telfer B; Yeung B; Levitt G; Ogilvie EE; Dharan NJ; Hammoud MA; Vaccher S; Watchirs-Smith L; McNulty A; Smith DJ; Allen DM; Baker D; Bloch M; Bopage RI; Brown K; Carr A; Carmody CJ; Collins KL; Finlayson R; Foster R; Jackson EY; Lewis DA; Lusk J; O'Connor CC; Ryder N; Vlahakis E; Read P; Cooper DA; Smith D; Ooi C; Martin S; Soo TM; Templeton D; Townson D; Forssman B; Doong N; Han Thai G; Anderson B; MacLeod H; Parkhill N, 2018, 'Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study', The Lancet HIV, vol. 5, pp. e629 - e637, http://dx.doi.org/10.1016/S2352-3018(18)30215-7

Grebely J; Dalgard O; Conway B; Cunningham EB; Bruggmann P; Hajarizadeh B; Amin J; Bruneau J; Hellard M; Litwin AH; Marks P; Quiene S; Siriragavan S; Applegate TL; Swan T; Byrne J; Lacalamita M; Dunlop A; Matthews GV; Powis J; Shaw D; Thurnheer MC; Weltman M; Kronborg I; Cooper C; Feld JJ; Fraser C; Dillon JF; Read P; Gane E; Dore GJ, 2018, 'Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial', The Lancet Gastroenterology and Hepatology, vol. 3, pp. 153 - 161, http://dx.doi.org/10.1016/S2468-1253(17)30404-1

Templeton DJ; Adam PCG; Varma R; Read P; Bourne C; Kao SC, 2018, 'Evaluation of knowledge and utility of the 2014 Australian sexually transmissible infection and HIV testing guidelines for asymptomatic men who have sex with men among general practitioners in Sydney', Sexual Health, vol. 15, pp. 96 - 98, http://dx.doi.org/10.1071/SH17113

Read P; Lothian R; Chronister K; Gilliver R; Kearley J; Dore GJ; van Beek I, 2017, 'Delivering direct acting antiviral therapy for hepatitis C to highly marginalised and current drug injecting populations in a targeted primary health care setting', International Journal of Drug Policy, vol. 47, pp. 209 - 215, http://dx.doi.org/10.1016/j.drugpo.2017.05.032

Chow EPF; Callander D; Fairley CK; Zhang L; Donovan B; Guy R; Lewis DA; Hellard M; Read P; Ward A; Chen MY; Kaldor J; Grulich A; Marshall L; O'Connor C; Wilson D; Dickson B; Ali H; Smith LW; Jackson E; Russell D; Vhalkis E; Gunathilake M; Nikitas A; O'Sullivan M; Allen D; Ryder N; Brown K; Smith D; Paramsothy Y; Palmer C; Davies S; McNulty A; Menon A; Parker A, 2017, 'Increased Syphilis Testing of Men Who Have Sex With Men: Greater Detection of Asymptomatic Early Syphilis and Relative Reduction in Secondary Syphilis', Clinical Infectious Diseases, vol. 65, pp. 389 - 395, http://dx.doi.org/10.1093/cid/cix326

Read P, 2017, 'Everything old is new again: Don't forget about syphilis', Medicine Today, vol. 18, pp. 49 - 52

Keen P; Conway DP; Cunningham P; McNulty A; Couldwell DL; Davies SC; Smith DE; Gray J; Holt M; O'Connor CC; Read P; Callander D; Prestage G; Guy R, 2017, 'Multi-centre field evaluation of the performance of the Trinity Biotech Uni-Gold HIV 1/2 rapid test as a first-line screening assay for gay and bisexual men compared with 4th generation laboratory immunoassays', Journal of Clinical Virology, vol. 86, pp. 46 - 51, http://dx.doi.org/10.1016/j.jcv.2016.11.006

Chronister KJ; Gilliver R; Kearley J; Lothian R; Dore GJ; Read P, 2017, 'P54 Treatment adherence among people who inject drugs taking directly observed direct acting antiviral therapy at Kirketon Road Centre', Journal of Virus Eradication, vol. 3, pp. 30 - 30, http://dx.doi.org/10.1016/s2055-6640(20)30795-0

Chronister KJ; Lothian R; Kearley J; Gilliver R; Read P, 2017, 'P55 Client acceptability and feasibility of expanded access to direct acting antiviral therapy for hepatitis at the Kirketon Road Centre', Journal of Virus Eradication, vol. 3, pp. 31 - 31, http://dx.doi.org/10.1016/s2055-6640(20)30796-2

Gilliver R; Machin W; Kearley J; Lothian R; Chronister KJ; Read P, 2017, 'O10 Treatment of Aboriginal and Torres Strait Islander clients with direct acting antivirals at the Kirketon Road Centre', Journal of Virus Eradication, vol. 3, pp. 4 - 4, http://dx.doi.org/10.1016/s2055-6640(20)30893-1

Foster R; Ali H; Crowley M; Dyer R; Grant K; Lenton J; Little C; Knight V; Read P; Donovan B; McNulty A; Guy R, 2016, 'Does Living Outside of a Major City Impact on the Timeliness of Chlamydia Treatment? A Multicenter Cross-Sectional Analysis', Sexually Transmitted Diseases, vol. 43, pp. 506 - 512, http://dx.doi.org/10.1097/OLQ.0000000000000496

Read P; Tagg KA; Jeoffreys N; Guy RJ; Gilbert GL; Donovan B, 2016, 'Treponema pallidum strain types and association with macrolide resistance in Sydney, Australia: New TP0548 gene types identified', Journal of Clinical Microbiology, vol. 54, pp. 2172 - 2174, http://dx.doi.org/10.1128/JCM.00959-16

Callander DJ; Read P; Prestage G; Minichiello V; Chow EPF; Lewis DA; McNulty A; Ali H; Hellard M; Guy R; Donovan B, 2016, 'A cross-sectional study of HIV and STIs among male sex workers attending Australian sexual health clinics', Sexually Transmitted Infections, vol. Published Online First 2 September 2016, pp. 299 - 302, http://dx.doi.org/10.1136/sextrans-2016-052578

Smith KS; Kaldor JM; Hocking JS; Jamil MS; McNulty AM; Read P; Bradshaw CS; Chen MY; Fairley CK; Wand H; Worthington K; Blake S; Knight V; Rawlinson W; Saville M; Tabrizi SN; Garland SM; Donovan B; Guy R, 2016, 'The acceptability and cost of a home-based chlamydia retesting strategy: Findings from the REACT randomised controlled trial', BMC Public Health, vol. 16, http://dx.doi.org/10.1186/s12889-016-2727-4

Marshall AD; Micallef M; Erratt A; Telenta J; Treloar C; Everingham H; Jones SC; Bath N; How-Chow D; Byrne J; Harvey P; Dunlop A; Jauncey M; Read P; Collie T; Dore GJ; Grebely J, 2015, 'Liver disease knowledge and acceptability of non-invasive liver fibrosis assessment among people who inject drugs in the drug and alcohol setting: The LiveRLife Study', International Journal of Drug Policy, vol. 26, pp. 984 - 991, http://dx.doi.org/10.1016/j.drugpo.2015.07.002

Smith KS; Hocking JS; Chen MY; Fairley CK; McNulty AM; Read P; Bradshaw CS; Tabrizi SN; Wand H; Saville M; Rawlinson W; Garland SM; Donovan B; Kaldor JM; Guy RJ, 2015, 'Dual Intervention to Increase Chlamydia Retesting: A Randomized Controlled Trial in Three Populations', American Journal of Preventive Medicine, vol. 49, pp. 1 - 11, http://dx.doi.org/10.1016/j.amepre.2015.01.014

Chan D; Stewart M; Smith M; Price T; Lusk J; Ooi C; Read P; Finlayson R, 2015, 'The rise of targeted HIV oral rapid testing in Australia', Medical Journal of Australia, vol. 202, pp. 251 - 254, http://dx.doi.org/10.5694/mja14.01292

Read P; Fairley CK; Chow EPF, 2015, 'Increasing trends of syphilis among men who have sex with men in high income countries', Sexual Health, vol. 12, pp. 155 - 163, http://dx.doi.org/10.1071/SH14153

Read PJ; Guy R; Jeoffreys N; Baker D; Shields M; Donovan B, 2015, 'Treatment and outcomes of polymerase chain reaction-confirmed early syphilis', Sexual Health, vol. 12, pp. 506 - 511, http://dx.doi.org/10.1071/SH15043

Smith KS; Hocking JS; Chen M; Fairley CK; McNulty A; Read P; Bradshaw CS; Tabrizi SN; Wand H; Saville M; Rawlinson W; Garland SM; Donovan B; Kaldor JM; Guy R, 2014, 'Rationale and design of REACT: A randomised controlled trial assessing the effectiveness of home-collection to increase chlamydia retesting and detect repeat positive tests', BMC Infectious Diseases, vol. 14, http://dx.doi.org/10.1186/1471-2334-14-223

Mcallister J; Read P; Mcnulty A; Tong W; Ingersoll A; Carr A, 2014, 'Raltegravir-emtricitabine-tenofovir as HIV nonoccupational post-exposure prophylaxis in men who have sex with men: Safety, tolerability and adherence', HIV Medicine, vol. 15, pp. 13 - 22, http://dx.doi.org/10.1111/hiv.12075

Templeton DJ; Read P; Varma R; Bourne C, 2014, 'Australian sexually transmissible infection and HIV testing guidelines for asymptomatic men who have sex with men 2014: A review of the evidence', Sexual Health, vol. 11, pp. 217 - 229, http://dx.doi.org/10.1071/SH14003

Read P; Jeoffreys N; Tagg K; Guy RJ; Gilbert GL; Donovan B, 2014, 'Azithromycin-resistant syphilis-causing strains in Sydney, Australia: Prevalence and risk factors', Journal of Clinical Microbiology, vol. 52, pp. 2776 - 2781, http://dx.doi.org/10.1128/JCM.00301-14

Mulhall BP; Wright S; Allen D; Brown K; Dickson B; Grotowski M; Jackson E; Petoumenos K; Read P; Read T; Russell D; Smith DJ; Templeton DJ; Fairley CK; Law MG, 2014, 'High rates of sexually transmissible infections in HIV-positive patients in the Australian HIV Observational Database: A prospective cohort study', Sexual Health, vol. 11, pp. 291 - 297, http://dx.doi.org/10.1071/SH13074

Ewing M; Read P; Knight V; Morgan S; Hanlon M; McDonald A; Mclver R; Wright S; McNulty A, 2013, 'Do callers to the NSW Sexual Health Infoline attend the services they are referred to?', Sexual Health, vol. 10, pp. 530 - 532, http://dx.doi.org/10.1071/SH13106

Martin L; Knight V; Read PJ; Mcnulty A, 2013, 'Fast-track services for all? The preferences of Chinese-, Korean-, and Thai-speaking women attending a sexual health service', Sexually Transmitted Diseases, vol. 40, pp. 929 - 932, http://dx.doi.org/10.1097/OLQ.0000000000000055

Read PJ; Limnios EA; McNulty A; Whiley D; Lahra MM, 2013, 'One confirmed and one suspected case of pharyngeal gonorrhoea treatment failure following 500mg ceftriaxone in Sydney, Australia', Sexual Health, vol. 10, pp. 460 - 462, http://dx.doi.org/10.1071/SH13077

McCann L; Allan W; Read P; McNulty A, 2013, 'Contact tracing using provider referral: How difficult is it?', Sexual Health, vol. 10, pp. 472 - 473, http://dx.doi.org/10.1071/SH13085

Read PJ; Knight V; Bourne C; Guy R; Donovan B; Allan W; Mcnulty AM, 2013, 'Community event-based outreach screening for syphilis and other sexually transmissible infections among gay men in Sydney, Australia', Sexual Health, vol. 10, pp. 357 - 362, http://dx.doi.org/10.1071/SH13012

Kwon I; Mcnulty A; Read P, 2013, 'The prevalence of Trichomonas vaginalis detected by wet mount and polymerase chain reaction in Sydney women', Sexual Health, vol. 10, pp. 385 - 386, http://dx.doi.org/10.1071/SH12201

Read PJ; McNulty A, 2013, 'Lymphogranuloma venereum presenting as genital ulceration and inguinal syndrome', Medical Journal of Australia, vol. 199, pp. 27 - 28, http://dx.doi.org/10.5694/mja13.10194

Smith KS; Hocking JS; Wand H; Chen M; Fairley CK; Bradshaw CS; Read P; McNulty A; Saville M; Tabrizi N, 2013, 'HOME-BASED SAMPLE COLLECTION INCREASES CHLAMYDIA RETESTING AND DETECTS ADDITIONAL REPEAT POSITIVE TESTS: A RANDOMISED CONTROLLED TRIAL IN THREE RISK GROUPS', SEXUALLY TRANSMITTED INFECTIONS, vol. 89, pp. A70 - A71, http://dx.doi.org/10.1136/sextrans-2013-051184.0215

Read PJ; Lucas S; Morris S; Kulasegaram R, 2013, 'Immune reconstitution inflammatory syndrome Kaposi sarcoma in the liver manifesting as acute obstructive hepatitis: another potential role for montelukast?', INTERNATIONAL JOURNAL OF STD & AIDS, vol. 24, pp. 156 - 158, http://dx.doi.org/10.1177/0956462412472819

Martin L; Knight V; Read PJ; McNulty A, 2013, 'Clients' preferred methods of obtaining sexually transmissible infection or HIV results from Sydney Sexual Health Centre', Sexual Health, vol. 10, pp. 91 - 92, http://dx.doi.org/10.1071/SH12062

Bateson D; Freedman E; Stewart M; Read P, 2012, 'The who, what and from where of STIs: Selective testing in asymptomatic patients', Medicine Today, vol. 13, pp. 12 - 21

Read PJ; Mandalia S; Khan P; Harrisson U; Naftalin C; Gilleece Y; Anderson J; Hawkins D; Taylor G; De ruiter A; De Ruiter A, 2012, 'When should HAART be initiated in pregnancy to achieve an undetectable HIV viral load by delivery?', AIDS, vol. 26, pp. 1095 - 1103, http://dx.doi.org/10.1097/QAD.0b013e3283536a6c

Guy R; Wand HC; Knight V; Kenigsberg A; Read PJ; McNulty AM, 2012, 'SMS reminders improve re-screening in women and heterosexual men with chlamydia infection at Sydney Sexual Health Centre: a before-and-after study.', Sexually Transmitted Infections, vol. 89, pp. 11 - 15, http://dx.doi.org/10.1136/sextrans-2011-050370

Read PJ; Wand HC; Guy R; Donovan B; McNulty A, 2012, 'Unprotected fellatio between female sex workers and their clients in Sydney, Australia', Sexually Transmitted Infections, vol. 88, pp. 581 - 584, http://dx.doi.org/10.1136/sextrans-2011-050430

Read PJ; Donovan B, 2012, 'Clinical aspects of adult syphilis', Internal Medicine Journal, vol. 42, pp. 614 - 620, http://dx.doi.org/10.1111/j.1445-5994.2012.02814.x

McManus H; O'Connor CC; Boyd MA; Broom J; Russell D; Watson K; Roth N; Read PJ, 2012, 'Long-term survival in HIV positive patients with up to 15 years of antiretroviral therapy', PLoS One, vol. 7, pp. Article numbere48839, http://dx.doi.org/10.1371/journal.pone.0048839

Read PJ; Martin L; McNulty A, 2012, 'Would you self-collect swabs in a unisex toilet?', Sexual Health, vol. 9, pp. 395 - 396, http://dx.doi.org/10.1071/SH12016

Kwan B; Ryder N; Knight V; Kenigsberg A; McNulty A; Read PJ; Bourne CP, 2012, 'Sensitivity of 20-minute voiding intervals in men testing for chlamydia trachomatis', Sexually Transmitted Diseases, vol. 39, pp. 405 - 406, http://dx.doi.org/10.1097/OLQ.0b013e318248a563

Lockwood T; Knight V; Hanlon M; Bourne C; Read P, 2011, 'Contact tracing impact on bacterial STI re-infection?', Australian nursing journal (July 1993), vol. 19, pp. 36 - 37

Drummond F; Ryder N; Wand H; Guy R; Read P; McNulty A; Wray L; Donovan B, 2011, 'IS SINGLE DOSE AZITHROMYCIN ADEQUATE FOR ASYMPTOMATIC RECTAL CHLAMYDIA?', SEXUALLY TRANSMITTED INFECTIONS, vol. 87, pp. A76 - A76, http://dx.doi.org/10.1136/sextrans-2011-050109.122

Guy R; Wand H; Read P; Kenigsberg A; Knight V; McNulty A, 2011, 'P5-S4.07 SMS reminders increase re-testing for repeat chlamydial infection in heterosexuals at a sexual health clinic', Sexually Transmitted Infections, vol. 87, pp. A324 - A324, http://dx.doi.org/10.1136/sextrans-2011-050108.548

Read P; Armstrong-James D; Tong CYW; Fox J, 2011, 'Missed opportunities for HIV testing--a costly oversight.', QJM, vol. 104, pp. 421 - 424, http://dx.doi.org/10.1093/qjmed/hcq236

Read PJ; Fox J, 2010, 'Infectious syphilis unmasking drug resistance in an individual with long-term virological suppression on antiretroviral therapy.', Sex Transm Infect, vol. 86, pp. 276 - 277, http://dx.doi.org/10.1136/sti.2010.043364

Tapsall JW; Read P; Carmody CJ; Bourne CP; Ray S; Limnios A; Sloots T; Whiley D, 2009, 'Two cases of failed ceftriaxone treatment in pharyngeal gonorrhoea verified by molecular microbiological methods', Journal of Medical Microbiology, vol. 58, pp. 683 - 687, http://dx.doi.org/10.1099/jmm.0.007641-0

Read P; Costelloe S; Mullen J; O'Shea S; Lyons F; Hay P; Welch J; Larbalestier N; Taylor G; de Ruiter A, 2008, 'New mutations associated with resistance not detected following zidovudine monotherapy in pregnancy when used in accordance with British HIV Association guidelines.', HIV Med, vol. 9, pp. 448 - 451, http://dx.doi.org/10.1111/j.1468-1293.2008.00594.x

Read P; Abbott R; Pantelidis P; Peters BS; White JA, 2008, 'Disseminated gonococcal infection in a homosexual man diagnosed by nucleic acid amplification testing from a skin lesion swab.', Sex Transm Infect, vol. 84, pp. 348 - 349, http://dx.doi.org/10.1136/sti.2008.030817

Gilliver R; Scholey K; Chronister K; van Beek I; Read P, 2015, 'TARGETED PRIMARY HEALTH CARE AND SEXUAL HEALTH SERVICES CAN DELIVER THE HEPATITIS C STRATEGY: ONE YEAR OF FIBROSCANS AT THE KIRKETON ROAD CENTRE (KRC)', in SEXUALLY TRANSMITTED INFECTIONS, BMJ PUBLISHING GROUP, pp. A193 - A194, http://dx.doi.org/10.1136/sextrans-2015-052270.501

Read PJ; Wand H; Guy R; McNulty A; Donovan B, 2011, 'UNPROTECTED FELLATIO AND PHARYNGEAL GONORRHOEA IN SYDNEY SEX WORKERS', in SEXUALLY TRANSMITTED INFECTIONS, B M J PUBLISHING GROUP, pp. A130 - A131, http://dx.doi.org/10.1136/sextrans-2011-050108.76

Kearley J; Gilliver R; Lothian R; Cunningham EB; Dore GJ; Read P, 2019, 'MAXIMISING ADHERENCE TO DIRECT-ACTING ANTI-VIRALS FOR HEPATITIS C AMONG STREET-BASED AND MARGINALISED CLIENTS USING AN OPIOID AGONIST TREATMENT PROGRAM: THE RESULTS OF DAILY DOSING', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 38, pp. S59 - S60, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000494890100150&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kearley J; Gilliver R; Lothian R; Dore GJ; Read P, 2019, 'WHEN TREATMENT ACCESS DOES NOT EQUAL TREATMENT INITIATION: AN ANALYSIS OF CLIENTS WHO DO NOT INITIATE DIRECT ACTING ANTIVIRALS FOR HEPATITIS C', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 38, pp. S60 - S60, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000494890100151&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Valerio H; Alavi M; Silk D; Treloar C; Milat A; Dunlop A; Holden J; Henderson C; Amin J; Read P; Degenhardt L; Dore G; Grebely J, 2019, 'Uptake of testing, linkage to care, and treatment for hepatitis C infection among people who inject drugs in Australia: The ETHOS Engage study', in JOURNAL OF HEPATOLOGY, ELSEVIER, AUSTRIA, Vienna, Vol. 70, pp. E42 - E42, presented at International Liver Congress / 54th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), AUSTRIA, Vienna, 10 April 2019 - 14 April 2019, http://dx.doi.org/10.1016/S0618-8278(19)30076-3

Grebely J; Cunningham EB; Dalgard O; Hajarizadeh B; Conway B; Powis J; Bruneau J; Feld J; Read P; Cooper C; Amin J; Bruggmann P; Lacombe K; Stedman C; Hellard M; Marks P; Dunlop A; Moriggia A; Applegate T; Litwin A; Matthews G; Dore G, 2019, 'Reinfection following successful HCV DAA therapy among people with recent injecting drug use', in JOURNAL OF HEPATOLOGY, ELSEVIER, AUSTRIA, Vienna, Vol. 70, pp. E732 - E733, presented at International Liver Congress / 54th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), AUSTRIA, Vienna, 10 April 2019 - 14 April 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000463481703222&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Hooshyar SH; Martinello M; Yee J; Bartlett S; Read P; Baker D; Post J; Finlayson R; Bloch M; Doyle J; Shaw D; Hellard M; Petoumenos K; Marks P; Applegate T; Dore G; Matthew G, 2019, 'Low HCV reinfection incidence following DAA treatment scale-up in people living with HIV in Australia', in JOURNAL OF HEPATOLOGY, ELSEVIER, AUSTRIA, Vienna, Vol. 70, pp. E734 - E734, presented at International Liver Congress / 54th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), AUSTRIA, Vienna, 10 April 2019 - 14 April 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000463481703225&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Machin W; Gilliver R; Chronister KJ; Stockburger T; Read P, 2018, 'UNDER THE BRIDGE: IMPACT OF NON-MEDICAL PROVISION OF TAKE HOME NALOXONE TO CLIENTS AT HIGH RISK OF OVERDOSE IN COMMUNITY SETTINGS', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 37, pp. S49 - S50, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000449495000125&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lintzeris N; Monds L; Bravo M; Read P; Harrod ME; Nielsen S, 2018, 'FINDINGS OF THE IMPLEMENTATION OF ORTHN (OVERDOSE RESPONSE WITH TAKE HOME NALOXONE) IN NEW SOUTH WALES', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 37, pp. S47 - S47, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000449495000119&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Gilliver R; Chronister KJ; Lothian R; Kearley J; Machin W; Read P, 2018, 'DAILY DOSING OF DIRECT ACTING ANTIVIRALS FROM A PUBLIC OPIOID SUBSTITUTION TREATMENT PROGRAM FOR MARGINALISED CLIENTS IN KINGS CROSS, SYDNEY', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 37, pp. S32 - S32, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000449495000083&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Chronister KJ; Salmon AM; Harrod ME; Jauncey M; Read P, 2018, 'PERCEPTIONS OF HIV PRE-EXPOSURE PROPHYLAXIS AMONG PEOPLE WHO INJECT DRUGS', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 37, pp. S22 - S22, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000449495000058&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Yee J; Dore GJ; Hanson J; Iser D; Danta M; Shaw D; Read P; Balcomb A; Post J; Faros J; Montebello M; Collie P; Hallinan R; Cooper L; Marks P; Hajarizadeh B; Matthews GV, 2018, 'High efficacy of HCV therapy following universal DAA access in Australia: the REACH-C cohort', in JOURNAL OF VIRAL HEPATITIS, WILEY, CANADA, Toronto, Vol. 25, pp. 54 - 54, presented at 16th International Symposium on Viral Hepatitis and Liver Diseases (ISVHLD), CANADA, Toronto, 14 June 2018 - 17 June 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000435101000087&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Dalgard O; Grebely J; Conway B; Cunningham E; Bruggmann P; Hajarizadeh B; Amin J; Marks P; Quiene S; Applegate TL; Swan T; Byrne J; Lacalamita M; Dunlop A; Bruneau J; Hellard ME; Matthews GV; Powis J; Shaw D; Thurnheer MC; Weltman M; Kronborg I; Cooper C; Feld JJ; Fraser C; Litwin A; Dillon J; Read P; Gane E; Dore GJ, 2018, 'Sofosbuvir and Velpatasvir for Hepatitis C Virus Infection in People with Recent Injecting Drug Use (Simplify): An Open-Label, Single-Arm, Phase 4, Multicentre Trial', in HEROIN ADDICTION AND RELATED CLINICAL PROBLEMS, PACINI EDITORE, Vol. 20, pp. 14 - 14, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000440974900004&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Martinello M; Bartlett S; Dore G; Bopage R; Finlayson R; Baker D; Bloch M; Doyle J; Shaw D; Hajkowicz K; Read P; Filep E; Lin L; Yee J; Applegate T; Hellard M; Matthews G, 2018, 'Universal access to DAA therapy paves the way for HCV control and elimination among people living with HIV in Australia', in Universal access to DAA therapy paves the way for HCV control and elimination among people living with HIV in Australia, Paris, France, presented at THE INTERNATIONAL LIVER CONGRESS 2018, Paris, France, 11 April 2018 - 15 April 2018

Grebely J; Dalgard O; Conway B; Cunningham E; Bruggmann P; Hajarizadeh B; Amin J; Marks P; Quiene S; Applegate TL; Swan T; Byrne J; Lacalamita M; Dunlop AJ; Bruneau J; Hellard ME; Matthews GV; Powis J; Shaw D; Thurnheer MC; Weltman M; Kronborg I; Cooper C; Feld JJ; Fraser C; Litwin AH; Dillon JF; Read P; Gane ED; Dore GJ, 2017, 'EFFICACY AND SAFETY OF SOFOSBUVIR/VELPATASVIR IN PEOPLE WITH CHRONIC HEPATITIS C VIRUS INFECTION AND RECENT INJECTING DRUG USE: THE SIMPLIFY STUDY', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 36, pp. 34 - 34, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000424000500085&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Grebely J; Dalgard O; Conway B; Cunningham E; Bruggmann P; Hajarizadeh B; Amin J; Marks P; Quiene S; Applegate TL; Swan T; Byrne J; Lacalamita M; Dunlop AJ; Bruneau J; Hellard ME; Matthews GV; Powis J; Shaw D; Thurnheer CM; Weltman M; Kronborg I; Cooper C; Feld JJ; Fraser C; Litwin A; Dillon J; Read P; Gane E; Dore GJ, 2017, 'Efficacy and safety of sofosbuvir/velpatasvir in people with chronic hepatitis C virus infection and recent injecting drug use: the SIMPLIFY study', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, NETHERLANDS, Amsterdam, Vol. 66, pp. S513 - S513, presented at International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, NETHERLANDS, Amsterdam, 19 April 2017 - 23 April 2017, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000401056601271&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Grebely J; Marshall AD; Krahe M; Erratt A; Telenta J; Treloar C; Jones SC; Adey S; Bath N; How-Chow D; Byrne J; Harvey P; Dunlop AJ; Applegate TL; Lamoury F; Mowat Y; Jauncey M; Read P; Gilliver R; Smith J; Collie T; Dore GJ, 2016, 'A LIVER HEALTH PROMOTION INTERVENTION INTEGRATING NON-INVASIVE LIVER DISEASE SCREENING IN DRUG AND ALCOHOL SETTINGS: THE LIVERLIFE STUDY', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 35, pp. 40 - 40, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000398381500109&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kearley J; Chronister KJ; Gilliver R; Read P, 2016, 'WHO RETURNS FOR NALOXONE RELENISHMENT? A REAL WORL D ANALYSIS OF CLIENTS RETURNING FOR NALOXONE AT THE KIRKETON ROAD CENTRE IN KINGS CROSS, SYDNEY', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 35, pp. 45 - 46, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000398381500123&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Gilliver R; Lothian R; Chronister KJ; Machin W; Kearley J; Read P, 2016, 'THE DOG ATE MY DACLATASVIR: REAL LIFE EXPERIENCES DELIVERING DIRECT ACTING ANTIVIRALS TO MARGINALISED, HOMELESS AND ACTIVE DRUG USERS AT THE KIRKETON ROAD CENTRE', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 35, pp. 39 - 39, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000398381500105&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kearley J; Gilliver R; Read P; Chronister KJ, 2016, 'INCORPORATING OVERDOSE MANAGEMENT INTO ROUTINE CARE OF PEOPLE WHO INJECT DRUGS WHO ARE UNDERGOING HEPATITIS C TREATMENT WITH DIRECT ACTING ANTIVIRALS AT THE KIRKETON ROAD CENTRE', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 35, pp. 46 - 46, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000398381500124&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lintzeris N; Monds L; Shanahan M; Harrod M; Nielsen S; Haber PS; Dunlop AJ; Ezard N; Nghi P; Read P; Manzie R; Lenton S; Jauncey M; Trimmingham T; Cairnduff S; Dietze PM, 2016, 'IMPLEMENTING TAKE-HOME NALOXONE INTO ROUTINE CARE IN DRUG AND ALCOHOL TREATMENT SERVICES, NEEDLE SYRINGE PROGRAMS AND PEER OUTREACH SERVICES IN NEW SOUTH WALES', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 35, pp. 10 - 10, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000398381500023&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Gilliver R; Scholey K; Van Beek I; Read P, 2015, 'EXPANDING ACCESS TO HEPATITIS CARE AMONG PEOPLE WHO INJECT DRUGS: ONE YEAR OF FIBROSCANS AT THE KIRKETON ROAD CENTRE', in DRUG AND ALCOHOL REVIEW, WILEY-BLACKWELL, Vol. 34, pp. 28 - 29, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000367694000078&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Chronister KJ; Tayler P; Read P; Van Beek I, 2015, 'EVALUATING A TARGETED APPROACH TO PERFORMANCE AND IMAGE ENHANCING DRUGS INJECTORS' NEEDLE SYRINGE PROGRAM ACCESS AT KIRKETON ROAD CENTRE', in DRUG AND ALCOHOL REVIEW, WILEY-BLACKWELL, Vol. 34, pp. 20 - 21, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000367694000057&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1